Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06409195
Status:
RECRUITING
Last Update Posted:
2024-05-10
First Post:
2024-04-15
Brief Title:
A Trial to Study the Safety and Efficacy of SM-020 Gel 10 in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers
Sponsor:
DermBiont Inc
Organization:
DermBiont Inc
Study Overview
Official Title:
Open-Label Study of the Safety and Efficacy of SM-020 Gel 10 in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Open-Label study evaluating safety and efficacy of SM-020 Gel 10 in subjects with Seborrheic Keratoses and Non-Melanoma Skin Cancers ie Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ Subjects will be enrolled into 1 of 5 cohorts Each cohort will enroll approximately 5-10 subjects with at least 1 eligible lesion to be treated A maximum of 5 lesions may be enrolled per subject Treatment for all subjects and all lesions will be twice daily for approximately 28 days Post treatment residual lesions may be excised per standard of care for histological evaluation The duration of the study is estimated to be approximately up to 12 weeks from the beginning of the Screening period until the last subjects last visit
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None